Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON53293Recruiting
Randomised, open-label trial in cardiac morbidity (2 arms), sponsored by Inselspital. Primary endpoint: Composite of major cardiovascular events and all-cause death. Started Jul 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON53293.